Crohn's disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) in accordance with the criteria for diagnosis of Crohn's disease; (2) mild or moderate disease activity index (CDAI) in patients with chronic active stage between 151 and 450; (3) syndrome or deficiency of spleen and kidney yang deficiency of spleen and stomach and qi stagnation and blood stasis; (4) age 16-70 years old, the gender is not limited; (5) patients who did not take any medication for CD symptoms, or only those with salicylic acid; (6) no prior hormone therapy or received hormone therapy (prednisone is less than or equal to 0.5mg/kg/day), over the past three months without the use of immunosuppressive agents or biologic agents; (7) voluntarily participated in this trial and signed the informed consent.
Exclusion criteria
Exclusion criteria: (1) pregnancy, pregnancy or lactation; (2) at the same time with heart, brain, liver, kidney and hematopoietic system of serious diseases; (3) patients with a simultaneous psychiatric or other severe disease; (4) in this study selected point regions are skin diseases, fistula, fistula and mutilated and to perform acupuncture treatment; (5) drug users who may lead to exacerbation of CD symptoms or affect the efficacy of the treatment method in this study because of other diseases; (6) patients with short bowel syndrome, symptoms of intestinal stenosis, who had received abdominal or gastrointestinal surgery in the past six months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Crohn's disease activity index;SES-CD; | — |
Secondary
| Measure | Time frame |
|---|---|
| Inflammatory bowel disease quesionnaire;Hospital Anxiety and depression scale;CRP, ESR and PLT; | — |
Countries
China